Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Hyneck

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
American Journal of Hospital Pharmacy|November 1, 1982
Documented effectiveness of clinical pharmacy servicesF M Gibson, M L Hyneck, J J Scherrer
American Journal of Hospital Pharmacy|September 1, 1981
Interference of cephalosporins and cefoxitin with serum creatinine determinationM L Hyneck, R R Berardi, R M Johnson
Drug Intelligence & Clinical Pharmacy|February 1, 1986
Metoclopramide removal during continuous ambulatory peritoneal dialysisR R Berardi, L A Cornish, M L Hyneck
American Journal of Hospital Pharmacy|November 1, 1981
Cimetidine clearance during intermittent and chronic peritoneal dialysisM L Hyneck, J F Murphy, D E Lipschutz
Journal of Chromatography|September 25, 1987
High-performance liquid chromatographic determination of tolmetin, tolmetin glucuronide and its isomeric conjugates in plasma and urineM L Hyneck, P C Smith, E Unseld, et al.
Journal of Pharmaceutical Sciences|June 1, 1985
Urinary protein binding, kinetics, and dynamics of furosemide in nephrotic patientsD E Smith, M L Hyneck, R R Berardi, et al.
Mutation Research|June 1, 1973
A study of triflupromazine in dominant-lethal, cytogenetic and host-mediated assaysV A Ray, H E Holden, J H Ellis, et al.
Journal of Toxicology and Environmental Health|November 11, 1975
A comparative study on the genetic effects of hycanthone and oxamniquineV A Ray, H E Holden, J H Ellis, et al.
American Journal of Hospital Pharmacy|May 1, 1979
Effect of pH on the stability of heparin in 5% dextrose solutionsR T Joy, M L Hyneck, R R Berardi, et al.
Clinical Pharmacy|May 1, 1982
Cimetidine pharmacokineticsM A Abate, M L Hyneck, I A Cohen, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
American Journal of Hospital Pharmacy|November 1, 1982
Documented effectiveness of clinical pharmacy servicesF M Gibson, M L Hyneck, J J Scherrer
American Journal of Hospital Pharmacy|September 1, 1981
Interference of cephalosporins and cefoxitin with serum creatinine determinationM L Hyneck, R R Berardi, R M Johnson
Drug Intelligence & Clinical Pharmacy|February 1, 1986
Metoclopramide removal during continuous ambulatory peritoneal dialysisR R Berardi, L A Cornish, M L Hyneck
American Journal of Hospital Pharmacy|November 1, 1981
Cimetidine clearance during intermittent and chronic peritoneal dialysisM L Hyneck, J F Murphy, D E Lipschutz
Journal of Chromatography|September 25, 1987
High-performance liquid chromatographic determination of tolmetin, tolmetin glucuronide and its isomeric conjugates in plasma and urineM L Hyneck, P C Smith, E Unseld, et al.
Journal of Pharmaceutical Sciences|June 1, 1985
Urinary protein binding, kinetics, and dynamics of furosemide in nephrotic patientsD E Smith, M L Hyneck, R R Berardi, et al.
Mutation Research|June 1, 1973
A study of triflupromazine in dominant-lethal, cytogenetic and host-mediated assaysV A Ray, H E Holden, J H Ellis, et al.
Journal of Toxicology and Environmental Health|November 11, 1975
A comparative study on the genetic effects of hycanthone and oxamniquineV A Ray, H E Holden, J H Ellis, et al.
American Journal of Hospital Pharmacy|May 1, 1979
Effect of pH on the stability of heparin in 5% dextrose solutionsR T Joy, M L Hyneck, R R Berardi, et al.
Clinical Pharmacy|May 1, 1982
Cimetidine pharmacokineticsM A Abate, M L Hyneck, I A Cohen, et al.
Pageof 3